The Patent Finder
US

Activatable INTERLEUKIN-2 Polypeptides and Methods of Use Thereof

US 12,534,505 In force
OverviewFamilyAssignmentsSources & methods

Term ends May 14, 2039 · Medium confidence

Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 11,535,658, US 11,981,716), so the cap could be lower.

Filed Oct 9, 2022 as application 18/045,160 · Granted Jan 27, 2026
Base term plus 87 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
2019 2039
Clock starts
May 14, 2019
Term ends
May 14, 2039
Granted
Jan 27, 2026
base term Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
87
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,696,724, US 11,352,403, US 11,535,658, US 11,981,716.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 87 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts May 14, 2019, when application PCT/US2019/032321, the earliest non-provisional in its chain, was filed (this one was filed Oct 9, 2022)May 14, 2039High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+87 days, USPTO patent term adjustment recordAug 9, 2039High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,696,724, US 11,352,403, US 11,535,658, US 11,981,716)capped to May 14, 2039Medium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderMay 14, 2039Medium confidence

This family

Application PCT/US2019/032321PCT application
no patent term
no patent term
US 10,696,724In force
May 2039
May 2039
US 11,352,403In force
May 2039
May 2039
US 11,981,716In force
no later than Jul 2039
no later than Jul 2039
US 11,535,658In force
no later than May 2039
no later than May 2039
US 12,534,505this patent
May 2039
May 2039
Application 19/423,455Pending
not computed
not computed
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Oct 23, 2022
Reel 61505, frame 831
Winston, WilliamWerewolf Therapeutics, Inc.Assignment of Assignor's Interest
Oct 23, 2022
Reel 61505, frame 839
Seidel-dugan, CynthiaWerewolf Therapeutics, Inc.Assignment of Assignor's Interest
Oct 23, 2022
Reel 61505, frame 845
Hicklin, DanielWerewolf Therapeutics, Inc.Assignment of Assignor's Interest
Oct 23, 2022
Reel 61505, frame 850
Baeuerle, PatrickWerewolf Therapeutics, Inc.Assignment of Assignor's Interest
Oct 23, 2022
Reel 61505, frame 856
Salmeron Garcia, Jose AndresWerewolf Therapeutics, Inc.Assignment of Assignor's Interest
Oct 23, 2022
Reel 61505, frame 861
Brodkin, HeatherWerewolf Therapeutics, Inc.Assignment of Assignor's Interest
Oct 23, 2022
Reel 61505, frame 871
Evnin, LukeMPM Asset Management LLCAssignment of Assignor's Interest
Oct 23, 2022
Reel 61505, frame 879
Bhaskar, VinayMPM Asset Management LLCAssignment of Assignor's Interest
Oct 23, 2022
Reel 61505, frame 884
MPM Asset Management LLCWerewolf Therapeutics, Inc.Assignment of Assignor's Interest
Oct 15, 2026
Reel 76677, frame 66
Werewolf Therapeutics, Inc.EMD Serono Research & Development Institute, Inc.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited